Search
Search Results
##search.searchResults.foundPlural##
-
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1680PDF: 1366HTML: 549 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1731PDF: 1121HTML: 161 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2795PDF: 912HTML: 5412 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2425PDF: 1734HTML: 779 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2290PDF: 869HTML: 3296 -
-
APLASTIC ANEMIA AND VIRAL HEPATITIS
1376PDF: 603HTML: 23270 -
-
-
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
8035PDF: 2553HTML: 2185Table 1.: 300Table 2.: 326Table 3.: 280Table 4.: 288 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2568PDF: 2000HTML: 203 -
-
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1610PDF: 913HTML: 3160 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1357PDF: 603HTML: 1731Figures: 230Fifures Sanz: 236tables Sanz: 246Untitled: 230 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9670PDF: 6386HTML: 88353Fig.1b: 322Fig.1c: 335Fig.2a: 327Fig.2b: 290Fig.4: 361Fig.2c: 309Fig.3: 306Tab.1: 368Tab.2: 338Tab.3: 333Tab.4: 384Fig1a: 320 -
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia
1970PDF: 590HTML: 380 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3378PDF: 1725HTML: 415 -
-
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3605PDF: 1729HTML: 4107 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2222PDF: 1146HTML: 15754COVER LETTER: 283 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRANSFUSION-DEPENDENT β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATIONS Challenges in Supportive Care, Equity, and Compassion at End of Life
1345PDF: 932Html: 228 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
5301PDF: 1406HTML: 1954Untitled: 256Untitled: 244 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3674PDF: 1739HTML: 765 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2845PDF: 1293HTML: 297 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1341PDF: 673HTML: 6947 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
2132PDF: 1162HTML: 292 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2682HTML: 376PDF: 1001 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3613PDF: 2147HTML: 7599 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1971PDF: 1291HTML: 385 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1796HTML: 737PDF: 954 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3929PDF: 1016HTML: 6901







